Eli Lilly has responded to criticism of high prices for insulin products in the US by launching ... The new generic will sell for a little under $140 per vial or around $265 for a five-pack ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular ...

The United States Food and Drug Administration says the shortage of Eli ... Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...